Exelixis, Inc. (EXEL) earnings
EXEL earnings moved a median of +1.02% by the close. Quarterly and annual EXEL reports and results, each read against the price at its own news timestamp. Back to the EXEL overview →
30 measured EXEL earnings events.
Where these EXEL earnings landedvs 28 measured EXEL earnings reactions
| Middle 50% of EXEL earnings reactions | -1.24% to +2.70% |
|---|---|
| Median reaction (to close) | +1.02% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 EXEL earnings events with a measured close landed between -1.24% and +2.70%; 61% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Exelixis Announces Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | +1.10% | -1.36% | |
| Form 10-Q EXELIXIS, INC. For: Jul 03 | SEC filing · Form 10-Q | +1.10% | -1.36% | |
| Exelixis to Release Second Quarter 2026 Financial Results on Wednesday, August 5, 2026 | Press release | +0.17% | +1.77% | |
| Exelixis Announces First Quarter 2026 Financial Results and Provides Corporate Update | Press release | -0.18% | +2.70% | |
| Form 10-Q EXELIXIS, INC. For: Apr 03 | SEC filing · Form 10-Q | -0.18% | +2.70% | |
| Exelixis to Release First Quarter 2026 Financial Results on Tuesday, May 5, 2026 | Press release | -0.79% | +1.12% | |
| Form 10-K EXELIXIS, INC. For: Jan 02 | SEC filing · Form 10-K | -2.53% | -1.20% | |
| Exelixis Announces Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | +2.63% | +0.93% | |
| Form 10-Q EXELIXIS, INC. For: Oct 03 | SEC filing · Form 10-Q | +2.63% | +0.93% | |
| Exelixis to Release Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 | Press release | +0.28% | +0.17% | |
| Exelixis Announces Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | -0.45% | — | |
| Form 10-Q EXELIXIS, INC. For: Jul 04 | SEC filing · Form 10-Q | -0.45% | — | |
| Exelixis to Release Second Quarter 2025 Financial Results on Monday, July 28, 2025 | Press release | +0.55% | -3.36% | |
| Exelixis Announces First Quarter 2025 Financial Results and Provides Corporate Update | Press release | +5.83% | +9.84% | |
| Form 10-Q EXELIXIS, INC. For: Apr 04 | SEC filing · Form 10-Q | +5.83% | +9.84% | |
| Exelixis to Release First Quarter 2025 Financial Results on Tuesday, May 13, 2025 | Press release | +0.55% | +1.64% | |
| Form 10-K EXELIXIS, INC. For: Jan 03 | SEC filing · Form 10-K | +3.67% | -1.21% | |
| Exelixis Announces Third Quarter 2024 Financial Results and Provides Corporate Update | Press release | +4.50% | +3.31% | |
| Form 10-Q EXELIXIS, INC. For: Sep 27 | SEC filing · Form 10-Q | +4.50% | +3.31% | |
| Exelixis to Release Third Quarter 2024 Financial Results on Tuesday, October 29, 2024 | Press release | -0.09% | +2.23% | |
| Exelixis Announces Second Quarter 2024 Financial Results and Provides Corporate Update | Press release | -0.52% | +6.08% | |
| Form 10-Q EXELIXIS, INC. For: Jun 28 | SEC filing · Form 10-Q | -0.52% | +6.08% | |
| Exelixis to Release Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 | Press release | +0.11% | -0.18% | |
| Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update | Press release | +1.99% | +1.60% | |
| Form 10-Q EXELIXIS, INC. For: Mar 29 | SEC filing · Form 10-Q | +1.99% | +1.60% | |
| Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024 | Press release | +0.31% | -0.13% | |
| Form 10-K EXELIXIS, INC. For: Dec 29 | SEC filing · Form 10-K | -2.32% | -4.32% | |
| Exelixis Announces Third Quarter 2023 Financial Results and Provides Corporate Update | Press release | -1.69% | -1.66% | |
| Form 10-Q EXELIXIS, INC. For: Sep 29 | SEC filing · Form 10-Q | -1.69% | -1.66% | |
| Exelixis to Release Third Quarter 2023 Financial Results on Wednesday, November 1, 2023 | Press release | -1.83% | -2.02% |
Keep exploring
More EXEL: analyst actions → · SEC filings → · EXEL overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Eagle Pharmaceuticals, Inc. (EGRX) | 555 | 0.00% | 44% |
| Titan Medical Inc. - Ordinary Shares (TMDI) | 552 | -0.06% | 43% |
| ACHAOGEN (AKAO) | 547 | -0.26% | 44% |
| FIBROCELL SCIENCE INC COMMON (FCSC) | 547 | -0.17% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.